Microalbuminuria in Children With and Without Diabetes
2 other identifiers
observational
203
1 country
1
Brief Summary
The purpose of the study is to learn more about Microalbuminuria in children with and without diabetes. Albumin is a protein that may be excreted in the urine. In some conditions, like kidney problems or diabetes, the amount of albumin in the urine increases. The purpose of this study is to measure concentration of albumin in the urine of diabetic children and compare to healthy children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2005
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
April 28, 2006
CompletedFirst Posted
Study publicly available on registry
May 3, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedResults Posted
Study results publicly available
January 31, 2024
CompletedJanuary 31, 2024
January 1, 2024
3.6 years
April 28, 2006
July 21, 2009
January 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Subjects With Normal Urinary Protein Excretion in Healthy and Diabetic Children, Assessed Over 1 Day.
during hospitalization
Study Arms (2)
diabetes group
6 to 18 years old males and females, with confirmed diagnosis of Type I or Type II Diabetes with no history of: kidney disease, documented urinary tract infection, cardiovascular disease, liver disease, nocturnal enuresis, metabolic disease other that diabetes, abnormal body temperature at start of study visit, no strenuous exercise 24 hours prior to start of study visit.
control group
6 to 18 years old males and females, with no history of: Type I or Type II Diabetes and/or other metabolic disease, kidney disease, documented urinary tract infection, cardiovascular disease, liver disease, nocturnal enuresis, abnormal body temperature at start of study visit, no strenuous exercise 24 hours prior to start of study visit.
Eligibility Criteria
Primary care/specialty clinincs and community
You may qualify if:
- Healthy children 6 to 18
- Diabetic children 6 to 18
You may not qualify if:
- kidney disease
- abnormal body temperature
- history of documented urinary tract infection
- metabolic disease other than diabetes mellitus
- circulatory disease
- liver disease
- strenuous exercise in prior 24 hours
- nocturnal enuresis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of New Mexico
Albuquerque, New Mexico, 87131, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Aaron Jacobs, MD
- Organization
- University of New Mexico
Study Officials
- PRINCIPAL INVESTIGATOR
Aaron Jacobs
University of New Mexico- Pediatric department
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2006
First Posted
May 3, 2006
Study Start
August 1, 2005
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
January 31, 2024
Results First Posted
January 31, 2024
Record last verified: 2024-01